Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PHARMACY "FAILURE TO WARN" SUIT IN ARIZONA MAY CHANGE RULES

Executive Summary

PHARMACY "FAILURE TO WARN" SUIT IN ARIZONA MAY CHANGE RULES on pharmacist liability "for failing to counsel," pharmacist/attorney David Brushwood, University of Florida, declared during a seminar at NARD's mid-October convention in Boston. Brushwood maintained that an Arizona appellate court's 1994 reversal of a summary judgment dismissal in Lasley v. Shrake changes "the general rule" established by post-1986 case law that "pharmacists do not have a general duty to warn" patients about potential adverse effects from prescription drugs.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS025263

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel